App aims to improve heart failure management through daily tracking

NCT ID NCT06750549

Completed Disease control Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile app designed to help people with heart failure monitor their blood pressure, weight, and heart rate daily. The app also tracks symptoms and medications, sharing the data with doctors to guide treatment. Researchers wanted to see if using the app leads to better medication use and improved quality of life over 90 days. The study involved 134 participants recently hospitalized for heart failure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ENGAGE-HF mobile application (a device for self-monitoring and clinician feedback)
What this could lead to: If successful, this app could help heart failure patients better manage their condition and improve medication use and quality of life.
What could go wrong: This is a small, completed study (134 participants) testing a monitoring tool, not a treatment. Results may not apply to all heart failure patients, and the app itself does not directly treat the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

Stanford Cardiovascular Clinic

Stanford, California, 94305, United States
The Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States
U-M Frankel Cardiovascular Center

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.